Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-01 O'Grady Brendan P. EVP, North America Commercial Sale −9,849 $10.83 $107K 93,231.49
2021-03-01 O'Grady Brendan P. EVP, North America Commercial Sale −63,278 $10.93 $691K 29,953.49
2021-03-01 Nazzi Gianfranco EVP, International Markets Sale −15,177 $10.85 $165K 60,410.36
2021-03-01 Nazzi Gianfranco EVP, International Markets Sale −60,410.36 $10.88 $657K 0
2021-03-01 Fridriksdottir Hafrun Executive VP, Global R&D Sale −10,912 $10.83 $118K 114,063.51
2021-03-01 Drape Eric Executive VP Global Operations Sale −9,795 $10.85 $106K 49,291
2021-03-01 Dethlefs Sven EVP Global Marketing&Portfolio Sale −7,486 $10.83 $81K 69,263.7
2021-03-01 Daniell Richard Exec. VP, European Commercial Sale −20,598 $10.85 $224K 10,765
2021-02-28 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +18,430 21,404.39
2021-02-28 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −18,430 55,290
2021-02-28 Schultz Kare President and CEO Option exercise +65,047 800,881
2021-02-28 Schultz Kare President and CEO Option exercise · Restricted Share Units −65,047 195,143
2021-02-28 Sabag Mark See "Remarks" below Option exercise +20,598 131,922
2021-02-28 Sabag Mark See "Remarks" below Option exercise · Restricted Share Units −20,598 61,795
2021-02-28 O'Grady Brendan P. EVP, North America Commercial Option exercise +24,934 103,080.49
2021-02-28 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −24,934 74,805
2021-02-28 Nazzi Gianfranco EVP, International Markets Option exercise +15,177 75,587.36
2021-02-28 Nazzi Gianfranco EVP, International Markets Option exercise · Restricted Share Units −15,177 45,534
2021-02-28 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise +18,430 18,430
2021-02-28 Kalif Eliyahu Sharon EVP, Chief Financial Officer Option exercise · Restricted Share Units −18,430 55,290

Page 49 of 76 · 1,517 trades